Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mallinckrodt PLC

www.mallinckrodt.com

Latest From Mallinckrodt PLC

Deals Shaping The Medical Industry, September 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2017.

Deals Medical Device

NuVasive Replaces CFO In Wake Of Poor Q2

Spine firm NuVasive has named Rajesh Asarpota as the company's new executive vice president and chief financial officer. He steps in after the previous CFO left following NuVasive's disappointing Q2 2017 results.

Appointments Medical Device

Deal Watch: GSK Declines Option As Ionis' Inotersen Nears Finish Line

Ionis will file polyneuropathy candidate in US and EU on its own, while GSK de-emphasizes rare diseases. Aclaris buys Confluence in earn-out-heavy deal, and Galena undertakes reverse merger with Sellas.

Deals M & A

Mallinckrodt's InfaCare Buy Leaves Room For Further Diversifying M&A

UK-based Mallinckrodt's purchase of InfaCare gives it a late-stage asset for severe jaundice in infants while leaving room for further M&A.

Companies M & A
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Metabolic Disorders
  • Neurology, Nervous System
  • Renal System
  • Respiratory, Pulmonary
  • Alias(es)
  • Mallinckrodt LLC
  • Mallinckrodt Inc.
  • Mallinckrodt Group, Inc.
  • Mallinckrodt Pharmaceuticals
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Mallinckrodt PLC
  • Senior Management
  • Mark Trudeau, Pres. & CEO
    Matthew Harbaugh, EVP, CFO
    Gary Phillips, MD, EVP, Chief Strategy Officer
    Steven Romano, MD, EVP, CSO
  • Contact Info
  • Mallinckrodt PLC
    Phone: 17 8463 6700
    3 Lotus Park
    The Causeway
    Staines-Upon-Thames, MO TW18 3AG
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register